SEC Tracker
Get the app

Crescent Biopharma CBIO

Insider filing for CBIO

Form
4
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Crescent Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Omeros OMER public float $172M, Jun 30, 2025
  2. Lexicon Pharmaceuticals LXRX public float $170M, Jun 30, 2025
  3. XOMA Royalty XOMA public float $168M, Jun 30, 2025
  4. Forte Biosciences FBRX public float $157M, Jun 30, 2025
  5. Tvardi Therapeutics TVRD public float $207M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.